The price action is understandable (from the technical perspective). Is simply closing the gap

Now, the news of data from other two patients (not available yet) is just outstanding. I was assuming 8 out of 10 improved. Period.

Now are we saying that possibly 10 out of 10 with improved immunological outcomes ???.

And possibly a large survival rate ???

Holy macaroni !!!!

Am I reading this right ???